<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>medixocentreのブログ</title>
<link>https://ameblo.jp/medixocentre/</link>
<atom:link href="https://rssblog.ameba.jp/medixocentre/rss20.xml" rel="self" type="application/rss+xml" />
<atom:link rel="hub" href="http://pubsubhubbub.appspot.com" />
<description>ブログの説明を入力します。</description>
<language>ja</language>
<item>
<title>Epclusaコスト：インドにおける肝炎治療コスト</title>
<description>
<![CDATA[ <p><font style="vertical-align: inherit;"><font style="vertical-align: inherit;">A long-term investigation of effective drugs to treat viral hepatitis C has led to the invention of the antiviral drug <a href="https://www.medixocentre.com/product-category/epclusa-tablets/" target="_blank"><span style="font-weight:bold;">Epclusa</span></a>. </font><font style="vertical-align: inherit;">This is a combination of velpatasvir and sofosbuvir. </font><font style="vertical-align: inherit;">This drug is available in tablet form and its effectiveness has been clinically proven in long-term experiments. </font><font style="vertical-align: inherit;">The country manufacturer of the means is Germany. </font></font><span style="font-weight:bold;"><font style="vertical-align: inherit;"><font style="vertical-align: inherit;"><a href="https://www.medixocentre.com/" target="_blank">medixocentre.com</a></font></font></span></p><p>&nbsp;</p>
]]>
</description>
<link>https://ameblo.jp/medixocentre/entry-12410702887.html</link>
<pubDate>Tue, 09 Oct 2018 15:14:12 +0900</pubDate>
</item>
</channel>
</rss>
